{
    "title": "Amgen sales rise, but shares off as investors await obesity data",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12693317/Amgen-quarter-sales-rise-5--profit-charge.html",
    "date": "2023-10-31",
    "keywords": [
        "drug",
        "amgen",
        "share",
        "year",
        "analyst",
        "quarter",
        "revenue",
        "horizon",
        "obesity",
        "market",
        "forecast",
        "disease",
        "beasley",
        "trial",
        "management",
        "bill",
        "officer",
        "deal",
        "street",
        "cancer",
        "repatha",
        "otezla",
        "reporting",
        "tuesday",
        "raise",
        "acquisition",
        "month",
        "profile",
        "move",
        "pill",
        "half",
        "midstage",
        "candidate",
        "amg133",
        "confidence",
        "card",
        "mechanism",
        "data",
        "michael",
        "research",
        "note",
        "demand",
        "weightloss",
        "decade",
        "investment",
        "capital",
        "start",
        "race",
        "biotechs",
        "decision",
        "pricing",
        "pressure",
        "eye",
        "tepezza",
        "krystexxa",
        "postacquisition",
        "estimate",
        "end",
        "range",
        "wall",
        "average",
        "business",
        "peter",
        "griffith",
        "phone",
        "interview",
        "trade",
        "commission",
        "contention",
        "selling",
        "insurance",
        "pharmacy",
        "benefit",
        "charge",
        "prostate",
        "amg340",
        "profit",
        "line",
        "blair",
        "version",
        "humira",
        "deena",
        "leo",
        "bengaluru",
        "editing",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}